Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs

Clinical Rheumatology(2020)10.1007/s10067-020-05372-1Source: DataRank Database

Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs is a research paper published in Clinical Rheumatology (2020). On theSindex it has a DataRank of 0. It has been cited 44 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

44 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.68)OA: closedTopics (41)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Mukaila A. Raji,Akhil Sood ORCID

Live enrichment

PubMed:32862311 OpenAlex:https://openalex.org/W3082986568

National Institutes of Health

Grant: R01-DA039192

National Institutes of Health

Grant: 5R01DA039192-06

Effectiveness, toxicity and safety of opioid and benzodiazepine substitutes

FWCI

2.68

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

closedLicense: Springer TDM

publisherhttps://link.springer.com/content/pdf/10.1007/s10067-020-05372-1.pdf

publisherhttps://link.springer.com/article/10.1007/s10067-020-05372-1/fulltext.html

journalhttps://doi.org/10.1007/s10067-020-05372-1

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32862311

https://dx.doi.org/10.1007/s10067-020-05372-1

Fields of Study

Systemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesInflammasome and immune disorders03 medical and health sciences0302 clinical medicineAgedAntirheumatic AgentsArthritis, RheumatoidCognitive DysfunctionEtanerceptHumansInflammation

MeSH Terms

EtanerceptAgedArthritis, RheumatoidHumansInflammationAntirheumatic AgentsCognitive Dysfunction

Keywords

MedicineRheumatoid arthritisEtanerceptRheumatologyDiseaseSystemic inflammationInternal medicineDementiaImmunologyPopulationArthritisInflammationPhysical therapyArthritis, RheumatoidAntirheumatic AgentsHumansCognitive DysfunctionAgedAgingBiologicsCognitionRheumatic diseases

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs

FAIR Checklist

Authors (2)

Funding (2 grants)

Impact

Open Access

Topics